PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532879
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532879
Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 9,218.21 Million in 2023, expanding at a CAGR of 8.20% from 2024 to 2032.
Real-time PCR, also known as quantitative PCR, is a widely used technology for quickly and accurately quantifying nucleic acid in different biological samples. This method measures the accumulation of DNA during a PCR reaction by monitoring the change in intensity of a fluorescent signal. By comparing the sample to a reference, the number of original copies of template DNA can be determined. Digital PCR, on the other hand, is a highly precise method for detecting and quantifying nucleic acid. In this approach, each sample is divided into thousands of individual reactions, such as droplets in the case of Droplet Digital PCR technology.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market- Market Dynamics
The increasing prevalence of genetic disorders is expected to propel market demand
Both digital PCR (dPCR) and quantitative PCR (qPCR) provide high sensitivity and specificity in the detection of genetic mutations and disorders. The prevalence of genetic disorders such as cystic fibrosis, muscular dystrophy, and rare diseases has led to an increased use of these technologies for accurate diagnosis and monitoring. According to the World Health Organization, genetic disorders and congenital abnormalities affect 2%-5% of live births, contribute to 30% of pediatric hospital admissions, and are responsible for 50% of childhood deaths in industrialized countries. Additionally, ongoing technological advancements and the expanding scope of research and clinical trials present growth opportunities for the market. However, regulatory and reimbursement issues may impede market growth.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.20% over the forecast period (2024-2032)
Based on Product Type segmentation, Quantitative PCR was predicted to show maximum market share in the year 2023
Based on Application segmentation, Clinical was the leading Product Type in 2023
Based on End-User segmentation, Hospitals and Diagnostic Centers was the leading Product Type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmented based on Product Type, Application, End-User, and Region.
The market is segmented into two divisions according to Product Type: Quantitative PCR and Digital PCR. Quantitative PCR holds the largest market share. Quantitative PCR and Digital PCR are sophisticated methods utilized for identifying and measuring nucleic acids. These techniques are essential in different sectors such as clinical diagnostics, research, and biotechnology.
The market is segmented into five categories according to Application: Clinical, Research, Pathogen Testing, Oncology Testing, Blood Screening, and Others. Clinical holds the largest share in the market. Digital PCR (dPCR) and Real-time PCR (qPCR) play a crucial role in clinical diagnostics because of their high sensitivity, specificity, and capability to offer quantitative data.
The market is segmented into six main categories according to End-User: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories. Hospitals and Diagnostic Centers are the dominant players in the market. Digital PCR (dPCR) and Real-time PCR (qPCR) play crucial roles in hospitals and diagnostic centers, each offering specific advantages based on their strengths.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market- Geographical Insights
The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries for business purposes. North America leads the market, driven by the rising demand for rapid diagnostic tests and the growing elderly population. The region boasts a well-established healthcare infrastructure with advanced diagnostic capabilities, fueling the demand for precise and quick diagnostic tests. North America's healthcare systems are adept at incorporating new technologies such as dPCR and qPCR. According to a report by Cowen & Company, the total market value for infectious disease diagnostics exceeds USD 3 billion annually in the United States alone. Europe follows as the second largest region for market growth, attributed to the increased utilization of biomarker profiling for disease diagnosis.
The competitive landscape of the Digital PCR (dPCR) and Real-time PCR (qPCR) market is characterized by innovation and specialization in high-sensitivity applications, with the qPCR market offering a wide range of products and cost-effective solutions. Companies in these markets are prioritizing technological advancements, strategic partnerships, and global expansion to seize growth prospects and overcome obstacles. R&D investments are being made to enhance dPCR technology, focusing on enhancing sensitivity, speed, and automation, with key areas of innovation including microfluidics and multiplexing capabilities.
Quantitative PCR (qPCR) and digital PCR (dPCR) offer precise quantification and sensitive, specific detection of nucleic acids. These methods are widely used in genomics research for various applications, such as detecting rare cells in liquid biopsies and quantifying pathogens in wastewater samples.
GLOBAL DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Phinergy
China Dynamics
Fuji Pigment
Xinjiang Joinworld Co., Ltd.
ACTXE Limited
De Nora Tech, Inc.
Duracell
IBM
Polyplus
Lithium Air Industries
Others